Shereen Katrak, MD, MPH

Photo of Shereen Katrak, MD, MPH

Email Shereen

Location Required
Varies, CA 00000

Visit CTSI Profile

  • Asst. Clinical Prof. & Consult, UCSF Chancellor/EVC/FAS
  • Clinical Fellow

Biography

I am interested in HIV/AIDS research with particular interest in the epidemiology of HIV-malaria co-infection in sub-Saharan Africa.

Awards

Displaying 1 - 12 of 12

  1. Katrak S, Flood J. Latent Tuberculosis and Current Health Disparities in California: Making the Invisible Visible. Am J Public Health. 2018 Nov; 108(S4):S242-S245. View on Pubmed
  2. Nankabirwa JI, Briggs J, Rek J, Arinaitwe E, Nayebare P, Katrak S, Staedke SG, Rosenthal PJ, Rodriguez-Barraquer I, Kamya MR, Dorsey G, Greenhouse B. Persistent parasitemia despite dramatic reduction in malaria incidence after 3 rounds of indoor residual spraying in Tororo, Uganda. J Infect Dis. 2018 Nov 01. View on Pubmed
  3. Katrak S, Nayebare P, Rek J, Arinaitwe E, Nankabirwa JI, Kamya M, Dorsey G, Rosenthal PJ, Greenhouse B. Clinical consequences of submicroscopic malaria parasitaemia in Uganda. Malar J. 2018 Feb 05; 17(1):67. View on Pubmed
  4. Katrak S, Murphy M, Nayebare P, Rek J, Smith M, Arinaitwe E, Nankabirwa JI, Kamya M, Dorsey G, Rosenthal P, Greenhouse B. Performance of Loop-Mediated Isothermal Amplification for the Identification of Submicroscopic Plasmodium falciparum Infection in Uganda. Am J Trop Med Hyg. 2017 Oct 09. View on Pubmed
  5. Rek J, Katrak S, Obasi H, Nayebare P, Katureebe A, Kakande E, Arinaitwe E, Nankabirwa JI, Jagannathan P, Drakeley C, Staedke SG, Smith DL, Bousema T, Kamya M, Rosenthal PJ, Dorsey G, Greenhouse B. Characterizing microscopic and submicroscopic malaria parasitaemia at three sites with varied transmission intensity in Uganda. Malar J. 2016 09 15; 15:470. View on Pubmed
  6. Katrak S, Park LP, Woods C, Muir A, Hicks C, Naggie S. Patterns of Healthcare Utilization Among Veterans Infected With Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) and Coinfected With HIV/HCV: Unique Burdens of Disease. Open Forum Infect Dis. 2016 Sep; 3(3):ofw173. View on Pubmed
  7. Katrak S, Day N, Ssemmondo E, Kwarisiima D, Midekisa A, Greenhouse B, Kamya M, Havlir D, Dorsey G. Community-wide Prevalence of Malaria Parasitemia in HIV-Infected and Uninfected Populations in a High-Transmission Setting in Uganda. J Infect Dis. 2016 Jun 15; 213(12):1971-8. View on Pubmed
  8. Babik JM, Katrak S, Miller S, Shah M, Chin-Hong P. Epstein-Barr virus encephalitis in a renal transplant recipient manifesting as hemorrhagic, ring-enhancing mass lesions. Transpl Infect Dis. 2015 Oct; 17(5):744-50. View on Pubmed
  9. Watkins ER, Shamasunder S, Cascino T, White KL, Katrak S, Bern C, Schwartz BS. Visceral leishmaniasis-associated hemophagocytic lymphohistiocytosis in a traveler returning from a pilgrimage to the Camino de Santiago. J Travel Med. 2014 Nov-Dec; 21(6):429-32. View on Pubmed
  10. Stout JE, Katrak S, Goswami ND, Norton BL, Fortenberry ER, Foust E, Leone PA. Integrated screening for tuberculosis and HIV in tuberculosis contact investigations: lessons learned in North Carolina. Public Health Rep. 2014 Jan-Feb; 129 Suppl 1:21-5. View on Pubmed
  11. Katrak S, Gasasira A, Arinaitwe E, Kakuru A, Wanzira H, Bigira V, Sandison TG, Homsy J, Tappero JW, Kamya MR, Dorsey G. Safety and tolerability of artemether-lumefantrine versus dihydroartemisinin-piperaquine for malaria in young HIV-infected and uninfected children. Malar J. 2009 Nov 30; 8:272. View on Pubmed
  12. Johnston SC, Rootenberg JD, Katrak S, Smith WS, Elkins JS. Effect of a US National Institutes of Health programme of clinical trials on public health and costs. Lancet. 2006 Apr 22; 367(9519):1319-27. View on Pubmed